|
Anisman H, Merali Z, Hayley S (2008). Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders. Prog Neurobiol 85: 1-74. Atcha Z, Rourke C, Neo AH, Goh CW, Lim JS, Aw CC, Browne ER, Pemberton DJ (2010). Alternative method of oral dosing for rats. J Am Assoc Lab Anim Sci 49: 335-343. Aubert A, Vega C, Dantzer R, Goodall G (1995). Pyrogens specifically disrupt the acquisition of a task involving cognitive processing in the rat. Brain Behav Immun 9: 129-148. Banerjee A, Periyasamy S, Wolf IM, Hinds TD, Jr., Yong W, Shou W, Sanchez ER (2008). Control of glucocorticoid and progesterone receptor subcellular localization by the ligand-binding domain is mediated by distinct interactions with tetratricopeptide repeat proteins. Biochemistry 47: 10471-10480. Chatterton DE, Nguyen DN, Bering SB, Sangild PT (2013). Anti-inflammatory mechanisms of bioactive milk proteins in the intestine of newborns. Int J Biochem Cell Biol 45: 1730-1747. Chien IC, Chou YJ, Lin CH, Bih SH, Chou P (2004). Prevalence of psychiatric disorders among National Health Insurance enrollees in Taiwan. Psychiatr Serv 55: 691-697. Chrousos GP (2009). Stress and disorders of the stress system. Nat Rev Endocrinol 5: 374-381. Costa JT, Mele M, Baptista MS, Gomes JR, Ruscher K, Nobre RJ, de Almeida LP, Wieloch T, Duarte CB (2016). Gephyrin Cleavage in In Vitro Brain Ischemia Decreases GABAA Receptor Clustering and Contributes to Neuronal Death. Mol Neurobiol 53: 3513-3527. Craske MG, Stein MB, Eley TC, Milad MR, Holmes A, Rapee RM, Wittchen HU (2017). Anxiety disorders. Nat Rev Dis Primers 3: 17024. Danese A, Moffitt TE, Pariante CM, Ambler A, Poulton R, Caspi A (2008). Elevated inflammation levels in depressed adults with a history of childhood maltreatment. Arch Gen Psychiatry 65: 409-415. Dantzer R, Kelley KW (2007). Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun 21: 153-160. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW (2008). From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9: 46-56. Dejager L, Pinheiro I, Puimege L, Fan YD, Gremeaux L, Vankelecom H, Libert C (2010). Increased glucocorticoid receptor expression and activity mediate the LPS resistance of SPRET/EI mice. J Biol Chem 285: 31073-31086. Dinel AL, Andre C, Aubert A, Ferreira G, Laye S, Castanon N (2011). Cognitive and emotional alterations are related to hippocampal inflammation in a mouse model of metabolic syndrome. PLoS One 6: e24325. Duman RS, Aghajanian GK, Sanacora G, Krystal JH (2016). Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants. Nat Med 22: 238-249. Eichler SA, Meier JC (2008). E-I balance and human diseases - from molecules to networking. Front Mol Neurosci 1: 2. Flandreau EI, Ressler KJ, Owens MJ, Nemeroff CB (2012). Chronic overexpression of corticotropin-releasing factor from the central amygdala produces HPA axis hyperactivity and behavioral anxiety associated with gene-expression changes in the hippocampus and paraventricular nucleus of the hypothalamus. Psychoneuroendocrinology 37: 27-38. Frank MG, Thompson BM, Watkins LR, Maier SF (2012). Glucocorticoids mediate stress-induced priming of microglial pro-inflammatory responses. Brain Behav Immun 26: 337-345. Galigniana NM, Ballmer LT, Toneatto J, Erlejman AG, Lagadari M, Galigniana MD (2012). Regulation of the glucocorticoid response to stress-related disorders by the Hsp90-binding immunophilin FKBP51. J Neurochem 122: 4-18. Gross C, Hen R (2004). The developmental origins of anxiety. Nat Rev Neurosci 5: 545-552. Hinds TD, Jr., Stechschulte LA, Cash HA, Whisler D, Banerjee A, Yong W, Khuder SS, Kaw MK, Shou W, Najjar SM, Sanchez ER (2011). Protein phosphatase 5 mediates lipid metabolism through reciprocal control of glucocorticoid receptor and peroxisome proliferator-activated receptor-gamma (PPARgamma). J Biol Chem 286: 42911-42922. Hoeijmakers L, Harbich D, Schmid B, Lucassen PJ, Wagner KV, Schmidt MV, Hartmann J (2014). Depletion of FKBP51 in female mice shapes HPA axis activity. PLoS One 9: e95796. Izzo E, Auta J, Impagnatiello F, Pesold C, Guidotti A, Costa E (2001). Glutamic acid decarboxylase and glutamate receptor changes during tolerance and dependence to benzodiazepines. Proc Natl Acad Sci U S A 98: 3483-3488. Karim N, Irshad S, Khan I, Mohammad A, Anis I, Shah MR, Khan I, Chebib M (2015). GABA(A) receptor modulation and neuropharmacological activities of viscosine isolated from Dodonaea viscosa (Linn). Pharmacol Biochem Behav 136: 64-72. Kawasaki BT, Hoffman KB, Yamamoto RS, Bahr BA (1997). Variants of the receptor/channel clustering molecule gephyrin in brain: distinct distribution patterns, developmental profiles, and proteolytic cleavage by calpain. J Neurosci Res 49: 381-388. Kneussel M, Brandstätter JH, Laube B, Stahl S, Müller U, Betz H (1999). Loss of postsynaptic GABA(A) receptor clustering in gephyrin-deficient mice. J Neurosci 19: 9289-9297. Krystal JH, Sanacora G, Blumberg H, Anand A, Charney DS, Marek G, Epperson CN, Goddard A, Mason GF (2002). Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol Psychiatry 1: S71-80. Liu GX, Cai GQ, Cai YQ, Sheng ZJ, Jiang J, Mei Z, Wang ZG, Guo L, Fei J (2007). Reduced anxiety and depression-like behaviors in mice lacking GABA transporter subtype 1. Neuropsychopharmacology 32: 1531-1539. Lukins MB, Manninen PH (2005). Hyperglycemia in patients administered dexamethasone for craniotomy. Anesth Analg 100: 1129-1133. McEwen BS (2007). Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev 87: 873-904. Nguyen MD, Julien JP, Rivest S (2002). Innate immunity: the missing link in neuroprotection and neurodegeneration? Nat Rev Neurosci 3: 216-227. Nicolaides NC, Galata Z, Kino T, Chrousos GP, Charmandari E (2010). The human glucocorticoid receptor: molecular basis of biologic function. Steroids 75: 1-12. Nuss P (2015). Anxiety disorders and GABA neurotransmission: a disturbance of modulation. Neuropsychiatr Dis Treat 11: 165-175. O'Connor JC, Lawson MA, Andre C, Moreau M, Lestage J, Castanon N, Kelley KW, Dantzer R (2009). Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry 14: 511-522. O'Leary JCr, Zhang B, Koren Jr, Blair L, Dickey CA (2013). The role of FKBP5 in mood disorders: action of FKBP5 on steroid hormone receptors leads to questions about its evolutionary importance. CNS Neurol Disord Drug Targets 12: 1157-1162. O'Leary JC, 3rd, Dharia S, Blair LJ, Brady S, Johnson AG, Peters M, Cheung-Flynn J, Cox MB, de Erausquin G, Weeber EJ, Jinwal UK, Dickey CA (2011). A new anti-depressive strategy for the elderly: ablation of FKBP5/FKBP51. PLoS One 6: e24840. Porsolt RD, Antn G, Blavet N, Jalfre M (1978). Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 47: 379-391. Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong JS, Knapp DJ, Crews FT (2007). Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 55: 453-462. Remus JL, Dantzer R (2016). Inflammation Models of Depression in Rodents: Relevance to Psychotropic Drug Discovery. Int J Neuropsychopharmacol 19. Riazi K, Galic MA, Pittman QJ (2010). Contributions of peripheral inflammation to seizure susceptibility: cytokines and brain excitability. Epilepsy Res 89: 34-42. Sandi C (2011). Glucocorticoids act on glutamatergic pathways to affect memory processes. Trends Neurosci 34: 165-176. Sieghart W, Fuchs K, Tretter V, Ebert V, Jechlinger M, Höger H, Adamiker D (1999). Structure and subunit composition of GABA(A) receptors. Neurochem Int 34: 379-385. Sigel E, Steinmann ME (2012). Structure, function, and modulation of GABA(A) receptors. J Biol Chem 287: 40224-40231. Stechschulte LA, Hinds TD, Jr., Ghanem SS, Shou W, Najjar SM, Sanchez ER (2014). FKBP51 reciprocally regulates GRalpha and PPARgamma activation via the Akt-p38 pathway. Mol Endocrinol 28: 1254-1264. Storer CL, Dickey CA, Galigniana MD, Rein T, Cox MB (2011). FKBP51 and FKBP52 in signaling and disease. Trends Endocrinol Metab 22: 481-490. Sulakhiya K, Kumar P, Gurjar SS, Barua CC, Hazarika NK (2015). Beneficial effect of honokiol on lipopolysaccharide induced anxiety-like behavior and liver damage in mice. Pharmacol Biochem Behav 132: 79-87. Sulakhiya K, Keshavlal GP, Bezbaruah BB, Dwivedi S, Gurjar SS, Munde N, Jangra A, Lahkar M, Gogoi R (2016). Lipopolysaccharide induced anxiety- and depressive-like behaviour in mice are prevented by chronic pre-treatment of esculetin. Neurosci Lett 611: 106-111. Tao L, Qiu Y, Fu X, Lin R, Lei C, Wang J, Lei B (2016). Angiotensin-converting enzyme 2 activator diminazene aceturate prevents lipopolysaccharide-induced inflammation by inhibiting MAPK and NF-kappaB pathways in human retinal pigment epithelium. J Neuroinflammation 13: 35. Thompson MD, Gallagher WJ, Iaizzo PA, Lanier WL (2000). The effect of chronic dexamethasone-induced hyperglycemia and its acute treatment with insulin on brain glucose and glycogen concentrations in rats. Anesthesiology 93: 1279-1284. Tretter V, Mukherjee J, Maric HM, Schindelin H, Sieghart W, Moss SJ (2012). Gephyrin, the enigmatic organizer at GABAergic synapses. Front Cell Neurosci 6: 23. Truett GE, Heeger P, Mynatt RL, Truett AA, Walker JA, Warman ML (2000). Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT). Biotechniques 29: 52-54. Tzamaloukas AH, Avasthi PS (1986). Effect of Hyperglycemia on Serum Sodium Concentration and Tonicity in Outpatients on Chronic Dialysis. American Journal of Kidney Diseases 7: 477-482. Vasconcelos AR, Cabral-Costa JV, Mazucanti CH, Scavone C, Kawamoto EM (2016). The Role of Steroid Hormones in the Modulation of Neuroinflammation by Dietary Interventions. Front Endocrinol (Lausanne) 7: 9. Walker MK, Boberg JR, Walsh MT, Wolf V, Trujillo A, Duke MS, Palme R, Felton LA (2012). A less stressful alternative to oral gavage for pharmacological and toxicological studies in mice. Toxicol Appl Pharmacol 260: 65-69. Warrier M, Hinds TD, Jr., Ledford KJ, Cash HA, Patel PR, Bowman TA, Stechschulte LA, Yong W, Shou W, Najjar SM, Sanchez ER (2010). Susceptibility to diet-induced hepatic steatosis and glucocorticoid resistance in FK506-binding protein 52-deficient mice. Endocrinology 151: 3225-3236. Webster EL, Lewis DB, Torpy DJ, Zachman EK, Rice KC, Chrousos GP (1996). In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation. Endocrinology 137: 5747-5750. Wei P, Liu Q, Li D, Zheng Q, Zhou J, Li J (2015). Acute nicotine treatment attenuates lipopolysaccharide-induced cognitive dysfunction by increasing BDNF expression and inhibiting neuroinflammation in the rat hippocampus. Neurosci Lett 604: 161-166. Wolf IM, Periyasamy S, Hinds T, Jr., Yong W, Shou W, Sanchez ER (2009). Targeted ablation reveals a novel role of FKBP52 in gene-specific regulation of glucocorticoid receptor transcriptional activity. J Steroid Biochem Mol Biol 113: 36-45. Yang L, Wang M, Guo YY, Sun T, Li YJ, Yang Q, Zhang K, Liu SB, Zhao MG, Wu YM (2016). Systemic inflammation induces anxiety disorder through CXCL12/CXCR4 pathway. Brain Behav Immun 56: 352-362. Yong W, Yang Z, Periyasamy S, Chen H, Yucel S, Li W, Lin LY, Wolf IM, Cohn MJ, Baskin LS, Sanchez ER, Shou W (2007). Essential role for Co-chaperone Fkbp52 but not Fkbp51 in androgen receptor-mediated signaling and physiology. J Biol Chem 282: 5026-5036. Yu W, Jiang M, Miralles CP, Li RW, Chen G, de Blas AL (2007). Gephyrin clustering is required for the stability of GABAergic synapses. Mol Cell Neurosci 36: 484-500. Yuan L, Liu S, Bai X, Gao Y, Liu G, Wang X, Liu D, Li T, Hao A, Wang Z (2016). Oxytocin inhibits lipopolysaccharide-induced inflammation in microglial cells and attenuates microglial activation in lipopolysaccharide-treated mice. J Neuroinflammation 13: 77. Zhang K, Pan X, Wang F, Ma J, Su G, Dong Y, Yang J, Wu C (2016). Baicalin promotes hippocampal neurogenesis via SGK1- and FKBP5-mediated glucocorticoid receptor phosphorylation in a neuroendocrine mouse model of anxiety/depression. Sci Rep 6: 30951.
|